Share on LinkedInShare on LinkedIn

ARTICLE · 01 SEPTEMBER 2014

Bombay HC Upholds India’s First Compulsory License

The order of the IPAB affirmed the order of the Controller of Patents to grant Compulsory License to NATCO for Bayer’s Indian patent on Nexavar.

IndiaIntellectual Property
  • The Bombay HC in this case has upheld the order of the IPAB, which affirmed the order of the Controller of Patents to grant Compulsory License to NATCO for Bayer's Indian patent on Sorafenib Tosyalte (Nexavar).
  • NATCO's application for Compulsory License of Patent was the first in India.
  • This case is significant as it gives certain new interpretation to the conditions that needs to be met under the Indian Patents Act, 1970 for grant of Compulsory License.
  • The Bombay HC held that in respect of medicine the adequate extent for meeting the demand of the drug has to be 100%.
  • The Bombay HC held that dual pricing can be applied to meet the requirement of the public and not for making available the drug under reasonably affordable price.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from